Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma
- 3 January 2015
- journal article
- Published by Springer Science and Business Media LLC in Cancer Immunology, Immunotherapy
- Vol. 64 (4), 419-427
- https://doi.org/10.1007/s00262-014-1651-7
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infectionMucosal Immunology, 2012
- Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumabProceedings of the National Academy of Sciences of the United States of America, 2011
- Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humansBlood, 2011
- Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastomaNeuro-Oncology, 2011
- CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survivalJournal of Clinical Neuroscience, 2010
- Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed GlioblastomaJournal of Clinical Oncology, 2010
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaThe New England Journal of Medicine, 2010
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate CancerThe New England Journal of Medicine, 2010
- Glioma cancer stem cells induce immunosuppressive macrophages/microgliaNeuro-Oncology, 2010
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaThe New England Journal of Medicine, 2005